Assessment of Respiratory Dysfunction in Obesity and the Use of IMT.
NCT ID: NCT07307417
Last Updated: 2025-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-12-31
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IMT Group
inspiratory muscle training
The IMT experimental group will undergo training with a load of 30% of PImax, assessed in the first inspiratory muscle strength test. Training will be conducted twice a day, with 30 breaths in each training session. From the second week onwards, the training load will be increased by 10% each week. The maximum load will be 60% of PImax. The intervention will last 6 weeks and will be performed daily.
placebo-IMT
placebo-IMT
The control group will perform simulated inspiratory muscle training with a constant load of 15% PImax. Training will take place 7 times a week, 60 breaths once a day. The intervention will last 6 weeks and will be performed daily.
Control group
No Intervention: IMT Control Group - IMT Control Group - participants who will not complete the IMT cycle.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inspiratory muscle training
The IMT experimental group will undergo training with a load of 30% of PImax, assessed in the first inspiratory muscle strength test. Training will be conducted twice a day, with 30 breaths in each training session. From the second week onwards, the training load will be increased by 10% each week. The maximum load will be 60% of PImax. The intervention will last 6 weeks and will be performed daily.
placebo-IMT
The control group will perform simulated inspiratory muscle training with a constant load of 15% PImax. Training will take place 7 times a week, 60 breaths once a day. The intervention will last 6 weeks and will be performed daily.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 30 and 60 (women and men),
* consent of the subject.
Exclusion Criteria
* acute illness that may affect the training programme: e.g. infection, renal failure,
* mental impairment preventing cooperation,
* mental disorders preventing contact and cooperation with the patient,
* pacemaker,
* pregnancy
* implanted electronic
* medical implants
* epilepsy
* metal implants.
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wroclaw University of Health and Sport Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paulina Okrzymowska
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dariusz Kałka, prof.
Role: PRINCIPAL_INVESTIGATOR
Wroclaw University of Health and Sport Sciences
Krystyna Rożek-Piechura, prof.
Role: STUDY_DIRECTOR
Wroclaw University of Health and Sport Sciences
Paulina Okrzymowska
Role: PRINCIPAL_INVESTIGATOR
Wroclaw University of Health and Sport Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wroclaw University of Health and Sport Sciences
Wroclaw, Dolny Śląsk, Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00913
Identifier Type: -
Identifier Source: org_study_id